Furthermore, we are seeing a resurgence of "AIDS exceptionalism" fatigue. Donors are tired. The public is distracted by climate migration and AI wars. The result? A 15% funding cut to PEPFAR (the U.S. President's Emergency Plan for AIDS Relief) that quietly went through last fall.
Suggested SEO Tags: AIDS 2026, HIV Cure Update, Long Acting PrEP, Global Health Equity, HIV and Aging, CRISPR HIV, U=U. aids 2026
AIDS in 2026 is a disease of choice —specifically, the political choice to finish the job. Furthermore, we are seeing a resurgence of "AIDS
The problem isn't dying of AIDS in 2026. It's living with HIV and facing a frail body at 60. Geriatric HIV care is the specialty no one trained for, and we are scrambling to catch up. The result
In Eastern Europe and Central Asia, infection rates are rising —not falling. Why? Geopolitics. The disruption of global supply chains (exacerbated by the economic volatility of the mid-2020s) has pushed HIV treatment to the bottom of the national priority list.